DAM
AERI

DLD Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

DLD Asset Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,000
Closed -$1.51M – 199
2022
Q3 		$1.51M Buy
+100,000
New +$1.16M 0.12% 103

DLD Asset Management's AERI Position: Q4 2022 in Review

DLD Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 100,000 shares — an estimated $1.51M sold.

DLD Asset Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $1.51M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • DLD Asset Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • DLD Asset Management sold 100,000 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.51M.
  • DLD Asset Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • DLD Asset Management's Aerie Pharmaceuticals position peaked at $1.51M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on DLD Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.